2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$6.60-$0.005 (-0.08%)
Price as of Jul 13, 2026 4:10 PM EDT- $268.6MMarket Cap
- -2.94%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$6.60-$0.005 (-0.08%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.60 | ||
Change | -$0.32 (-4.62%) | ||
Open | $6.81 | ||
High | $6.90 | ||
Low | $6.51 | ||
Previous Close | $6.92 | ||
Volume | 284,674 | ||
30-Day Average Volume | 363,722 | ||
1-Week Change | -12.35% | ||
1-Month Change | 2.17% | ||
1-Year Change | -2.94% | ||
3-Year Change | -59.16% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.8M | ||
Total Assets | $335.5M | ||
Market Cap | $268.6M | ||
Enterprise Value | $192.2M | ||
Period: QTR TTM FY | |||
Revenue | $875,000.00 | ||
Net Income | -$39.7M | ||
Free Cash Flow | -$41.7M | ||
EBIT | -$39.7M | ||
EBITDA | -$38.9M | ||
Net Working Capital | $247.7M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 220 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 8 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue